IL1RN and metastatic malignant neoplasm in the lymph nodes: Patients with an advanced clinical stage (Fig. 4d), advanced T stage (Fig. 4e) and lymph node metastasis (Fig. 4f) tended to have decreased IL1RN methylation levels.